Screener
Solid Biosciences Inc. SLDB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$54.8M-38.8% | -$56.74M-44.4% | -$49.79M-16.9% | -$45.78M-39.9% | -$39.48M-57.5% | ||
| $391K+1.3% | $395K-2.9% | $467K-4.3% | $376K-7.2% | $386K-68.7% | ||
| $5.62M+78.6% | $5.15M+54.2% | $6.5M+70.1% | $3.93M+31.2% | $3.15M+50.3% | ||
| -$52.59M-40.6% | -$47.23M-48.3% | -$53.56M-80.7% | -$33.47M-41.2% | -$37.41M-74.3% | ||
| $150K-60.2% | $165K+31.0% | $565K+177% | $85K+467% | $377K+31.8% | ||
| -$133.59M-308% | $44.76M+263% | —— | -$45.27M-312% | -$32.73M-532% | ||
| $0-100% | $0-100% | $203K+58.6% | $243K+102% | $142K-36.9% | ||
| $48.47M— | $239.03M+26.0% | $5.14M-25.9% | $1.18M-63.9% | $0-100% | ||
| —— | $236.56M+81.4% | -$1.4M-109% | -$77.57M-147% | -$71.75M— | ||
| -$52.74M-39.6% | -$47.4M-48.2% | -$54.12M-81.3% | -$33.56M-41.5% | -$37.79M-73.7% |
FAQ
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$186.8M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $965.0K of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$187.8M over the trailing twelve months, down 52.3% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.